SG11201902465TA - Inhibitors of mtor-deptor interactions and methods of use thereof - Google Patents

Inhibitors of mtor-deptor interactions and methods of use thereof

Info

Publication number
SG11201902465TA
SG11201902465TA SG11201902465TA SG11201902465TA SG11201902465TA SG 11201902465T A SG11201902465T A SG 11201902465TA SG 11201902465T A SG11201902465T A SG 11201902465TA SG 11201902465T A SG11201902465T A SG 11201902465TA SG 11201902465T A SG11201902465T A SG 11201902465TA
Authority
SG
Singapore
Prior art keywords
international
deptor
inhibitors
pct
rule
Prior art date
Application number
SG11201902465TA
Other languages
English (en)
Inventor
Alan Lichtenstein
Michael E Jung
Joseph F Gera
Jihye Lee
Yijiang Shi
Original Assignee
Univ California
The Us Gov Represented By The Department Of Veterans Affairs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California, The Us Gov Represented By The Department Of Veterans Affairs filed Critical Univ California
Publication of SG11201902465TA publication Critical patent/SG11201902465TA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72—Hydrazones
    • C07C251/84—Hydrazones having doubly-bound carbon atoms of hydrazone groups being part of rings other than six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/02—Compounds containing any of the groups, e.g. carbazates
    • C07C281/04—Compounds containing any of the groups, e.g. carbazates the other nitrogen atom being further doubly-bound to a carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG11201902465TA 2016-11-07 2017-11-06 Inhibitors of mtor-deptor interactions and methods of use thereof SG11201902465TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662418362P 2016-11-07 2016-11-07
PCT/US2017/060116 WO2018085753A1 (en) 2016-11-07 2017-11-06 Inhibitors of mtor-deptor interactions and methods of use thereof

Publications (1)

Publication Number Publication Date
SG11201902465TA true SG11201902465TA (en) 2019-05-30

Family

ID=62076420

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201902465TA SG11201902465TA (en) 2016-11-07 2017-11-06 Inhibitors of mtor-deptor interactions and methods of use thereof

Country Status (13)

Country Link
US (1) US20190330142A1 (ja)
EP (1) EP3535239A1 (ja)
JP (1) JP2019535815A (ja)
KR (1) KR20190114955A (ja)
CN (1) CN109952287A (ja)
AU (1) AU2017355566A1 (ja)
BR (1) BR112019008606A2 (ja)
CA (1) CA3039070A1 (ja)
IL (1) IL266344A (ja)
MX (1) MX2019005294A (ja)
RU (1) RU2019112671A (ja)
SG (1) SG11201902465TA (ja)
WO (1) WO2018085753A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102114899B1 (ko) * 2020-02-26 2020-05-26 가천대학교 산학협력단 mSIN1 단백질 억제제를 유효성분으로 함유하는 불임 또는 유산의 예방 또는 치료용 약학적 조성물
KR102147491B1 (ko) * 2020-05-29 2020-08-25 가천대학교 산학협력단 DEPTOR 단백질 억제제 또는 mSIN1 단백질 억제제를 유효성분으로 함유하는 불임 또는 유산의 예방 또는 치료용 약학적 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3882152A (en) * 1970-09-09 1975-05-06 Air Prod & Chem Beta cyclopentadienyl hydrazides and carbazates

Also Published As

Publication number Publication date
RU2019112671A (ru) 2020-12-07
JP2019535815A (ja) 2019-12-12
US20190330142A1 (en) 2019-10-31
CA3039070A1 (en) 2018-05-11
AU2017355566A1 (en) 2019-04-04
CN109952287A (zh) 2019-06-28
BR112019008606A2 (pt) 2019-07-09
IL266344A (en) 2019-06-30
KR20190114955A (ko) 2019-10-10
MX2019005294A (es) 2019-10-14
EP3535239A1 (en) 2019-09-11
WO2018085753A1 (en) 2018-05-11

Similar Documents

Publication Publication Date Title
SG11201811490XA (en) Cd3 binding antibodies
SG11201807252QA (en) Anti-lag-3 antibodies
SG11201909949XA (en) Targeted immunotolerance
SG11201805709RA (en) Anti-pro/latent myostatin antibodies and methods of use thereof
SG11201908560SA (en) Heterocyclic compounds useful as dual atx/ca inhibitors
SG11201809857TA (en) Anti-CTLA-4 Antibodies
SG11201903697WA (en) Liver organoid compositions and methods of making and using same
SG11201805570WA (en) Systems and methods for long term transdermal administration
SG11201804132UA (en) Eif4-a-inhibiting compounds and methods related thereto
SG11201803906PA (en) Control of cellular redox levels
CA3025288C (en) Reduced misting alkaline and neutral cleaning, sanitizing, and disinfecting compositions via the use of high molecular weight water-in-oil emulsion polymers
SG11201407534PA (en) New diazaspirocycloalkane and azaspirocycloalkane
SG11201900554YA (en) Spiro-lactam nmda modulators and methods of using same
SG11201900634VA (en) Chimeric antigen receptor
SG11201908472VA (en) Compositions and methods for activating nk cells
SG11201808222RA (en) Methods of treatment of cholestatic diseases
SG11201806544XA (en) Compounds and methods of treating rna-mediated diseases
SG11201900551WA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201805149XA (en) Compositions comprising 15-hepe and methods of using the same
SG11201900546UA (en) Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereof
SG11201908929VA (en) Synthekine compositions and methods of use
SG11201900558RA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201909003YA (en) Integrated vascular access device and anchor pad
SG11201907196YA (en) Composition and methods for preventing radiation injury and promoting tissue regeneration
SG11201808525UA (en) Anti-complement factor bb antibodies and uses thereof